Profitability • Atrium Therapeutics
RNA
Atrium Therapeutics Inc. is a clinical-stage biopharmaceutical company pioneering the development of atrial-selective gene therapies for the treatment of atrial fibrillation (AFib), the most prevalent sustained cardiac arrhythmia worldwide. The company's mission is to provide a durable, one-time treatment that restores and maintains normal sinus rhythm, addressing the limitations of current standard-of-care treatments such as anti-arrhythmic drugs and catheter ablation. Atrium's proprietary platform focuses on localized delivery of genetic material to the heart's atria. Its lead product candidate, ATR-101, is an investigational gene therapy designed to be delivered via a single administration to the epicardial surface of the atria during a minimally invasive procedure or concomitant with cardiac surgery. ATR-101 works by expressing a modified potassium channel that prolongs the atrial refractory period, thereby suppressing the electrical triggers and substrates that sustain AFib. By targeting the underlying electrophysiological mechanisms of the disease specifically within the atrial tissue, Atrium Therapeutics aims to minimize systemic side effects and improve long-term outcomes for patients suffering from paroxysmal or persistent AFib. The company is positioned at the intersection of cardiovascular medicine and advanced genetic therapeutics, seeking to fill a significant unmet need in the management of chronic heart rhythm disorders.
100%
Gross Margin
Gross margin measures the amount of revenue that remains after subtracting costs directly associated with production.
—
EBITDA Margin
The EBITDA margin is a measure of a company's operating profit desconsidering D&A costs as a percentage of its revenue.
—
EBIT Margin
The EBIT margin is a measure of a company's operating profit considering D&A costs as a percentage of its revenue.
—
Net Margin
The net profit margin, or simply net margin, measures how much net income or profit is generated as a percentage of revenue. It is the ratio of net profits to revenues for a company or business segment.
0%
D&A/EBITDA
Many companies have a high D&A in relation to the company's operating profit (EBITDA) and although this indicator does not have an effective cash effect, it ends up influencing the accounting net income, so analyzing this relationship can help to understand when D&A has a relevant impact to the company's results.
2981,4%
R&D/Revenue
Shows the amount spent on investments in research and development in relation to the Net Revenue for the period. The company can use these investments to try to increase its revenue in the future.
71%
Capex/Revenue
Shows the amount spent on investments in Capex in relation to Net Revenue for the period. The company can use these investments to try to increase its revenue in the future.
320,9%
Capex/D&A
Indicates a comparison between investments in fixed/intangible assets and the depreciation and amortization of some company assets. It serves to let managers know that the company's assets are devaluing periodically, and whether CAPEX has followed the same pace or not.
-2%
Capex/OCF
It shows the percentage of operating cash flow that the company uses in Capex (investments in fixed and intangible assets). When your result is greater than 100%, it demonstrates that there are expenses greater than what the company produces in its operations.
—
SBC/OCF
It demonstrates the percentage cost of Stock-Based Compensation compared to the company's operating cash flow. In some companies, the OCF is positive because of the SBC, which can lead to an incorrect cash flow analysis.
65,9%
% PPE
If the company has a lot of D&A, it helps to see if most of it tends to come from fixed assets. The account can include machinery, equipment, vehicles, buildings, land, office equipment, and furnishings, among other things.
0%
% Goodwill
If the company has a lot of D&A, it helps to see if most of it tends to come from Goodwill, that is an intangible asset that accounts for the excess purchase price of another company.
—
ROE
Return on equity (ROE) is the measure of a company's net income divided by its shareholders' equity and is a gauge of a corporation's profitability and how efficiently it generates those profits.
—
ROIC
Return on invested capital (ROIC) is a calculation used to assess a company's efficiency in allocating capital to profitable investments. The formula for calculating ROIC involves dividing Net Income by the average of invested capital.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!